Page last updated: 2024-11-05

xylazine and Cardiac Diseases

xylazine has been researched along with Cardiac Diseases in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sterba, M1
Simůnek, T1
Popelová, O1
Potácová, A1
Adamcová, M1
Mazurová, Y1
Holecková, M1
Gersl, V1

Other Studies

1 other study available for xylazine and Cardiac Diseases

ArticleYear
Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination.
    Physiological research, 2007, Volume: 56, Issue:5

    Topics: Anesthetics; Animals; Antibiotics, Antineoplastic; Biomarkers; Blood Pressure; Calcium; Collagen; Da

2007